Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: AIDS Behav. 2018 Jan;22(1):287–296. doi: 10.1007/s10461-017-1680-2

Figure 2.

Figure 2

Allocation status and follow-up of 356 HIV-positive adults enrolled in a cluster randomized trial of DOT-cART

* Virologic failure was defined as two consecutive detectable viral loads after achieving virologic suppression or cART change due to virologic failure.

** Among 180 and 138 participants alive and on treatment at 12-months in the DOT and No-DOT centers, respectively.